MedPage Today on MSN
GLP-1 Microdosing and Longevity; Near 30% Weight Loss in Trial; 2025's Top Research
Meanwhile, people with overweight or obesity lost up to 11.3% more weight than placebo by week 36 with a novel GLP-1 agonist ...
They’ve been billed as “miracle drugs,” promising weight loss, improved heart health, and better blood sugar control. But as ...
Everyday Health on MSN
The 11 best sites to buy GLP-1 weight loss medications online, reviewed by experts in 2026
Discover the top 11 websites to buy GLP-1 weight loss medications online. Our expert-reviewed guide helps you find safe, ...
By taking into account a patient’s unique biology, psychology, environment and behaviors, Hims & Hers is able to offer access ...
GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...
Jess Loren, GLP-1 user, shares another side effect of taking Ozempic: “It happened pretty instantly”
GLP-1 weight loss drugs are proving beneficial for people struggling with obesity and diabetes, but there is another surprising side effect coming to light.
The ever-expanding popularity of GLP-1 drugs for weight loss is challenging employers to balance access and cost.
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...
Newspoint on MSN
Exploring MyStart GLP-1: A new approach to weight loss
Introduction to MyStart GLP-1 My journey into weight loss began not with the desire for another catchy headline, but rather ...
Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study for cats. MEOW-1, as the study is called, will look to use OKV-119, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results